DK2708147T3 - Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose - Google Patents

Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose Download PDF

Info

Publication number: DK2708147T3
Authority: DK; Denmark
Prior art keywords: fucosyl; lactose; procedures; increasing brain; brain functionality
Prior art date: 2012-09-14

Application number

DK12382356.9T

Other languages

English (en)

Inventor

Hernandez Enrique Vazquez

Cabrera Ricardo Rueda

Rachael Buck

Perez Alejandro Barranco

Gonzales Maria Ramirez

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-14

Filing date

2012-09-14

Publication date

2020-05-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46940437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2708147(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-09-14 Application filed by Abbott Lab filed Critical Abbott Lab

2020-05-18 Application granted granted Critical

2020-05-18 Publication of DK2708147T3 publication Critical patent/DK2708147T3/da

Links

HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 title 1
210000004556 brain Anatomy 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Pediatric Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

DK12382356.9T 2012-09-14 2012-09-14 Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose DK2708147T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP12382356.9A EP2708147B1 (en)	2012-09-14	2012-09-14	Methods for increasing brain functionality using 2-fucosyl-lactose

Publications (1)

Publication Number	Publication Date
DK2708147T3 true DK2708147T3 (da)	2020-05-18

Family

ID=46940437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK12382356.9T DK2708147T3 (da)	2012-09-14	2012-09-14	Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose

Country Status (13)

Country	Link
US (1)	US10398715B2 (da)
EP (2)	EP2708147B1 (da)
CN (1)	CN104780785A (da)
BR (1)	BR112015005794A2 (da)
CA (1)	CA2884634A1 (da)
DK (1)	DK2708147T3 (da)
ES (1)	ES2795665T3 (da)
IL (1)	IL237617A0 (da)
MX (2)	MX385855B (da)
MY (1)	MY180148A (da)
PH (1)	PH12015500546A1 (da)
SG (1)	SG11201501893XA (da)
WO (1)	WO2014043368A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2572831T3 (es)	2012-09-14	2016-06-02	Abbott Laboratories	Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP2888950A1 (en) *	2013-12-24	2015-07-01	Abbott Laboratories	Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
CN106998775A (zh) *	2014-11-26	2017-08-01	雅培制药有限公司	具有RRR‑α‑生育酚、2’‑岩藻糖基乳糖和益生菌的婴儿配方
WO2016086157A1 (en) *	2014-11-26	2016-06-02	Abbott Laboratories	Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
US10780103B2 (en)	2015-10-28	2020-09-22	Glycom A/S	Synthetic composition and method for modulating emotion and mood disorders
US10835545B2 (en)	2015-10-28	2020-11-17	Glycom A/S	Synthetic composition and method for modulating brain function and behaviour
KR101731263B1 (ko) *	2016-04-25	2017-05-02	서울대학교 산학협력단	코리네박테리움 글루타미쿰을 이용한 2'-푸코실락토오스의 생산방법
WO2017215722A1 (en) *	2016-06-15	2017-12-21	Glycom A/S	Synthetic composition comprising hmo and method for modulating emotion and mood disorders
NZ750365A (en)	2016-07-28	2022-07-01	Fonterra Cooperative Group Ltd	Dairy product and process
WO2018215572A1 (en) *	2017-05-24	2018-11-29	Nestec S.A.	Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
WO2018215406A1 (en) *	2017-05-24	2018-11-29	Nestec S.A.	A nutritional composition for use to enhance attention and/or reduce impulsivity
CN110769703A (zh) *	2017-05-24	2020-02-07	雀巢产品有限公司	用于改善短期记忆和其他认知益处的包含低聚果糖(of)的组合物
KR101953375B1 (ko)	2017-11-20	2019-02-28	고려대학교 산학협력단	다양하고 신규한 퓨코실 올리고당의 제조법 및 이의 용도
KR20190130720A (ko) *	2018-05-15	2019-11-25	(주)에이피테크놀로지	2'-푸코실락토오스를 포함하는 뇌졸중 예방용 조성물
WO2020001862A1 (en)	2018-06-25	2020-01-02	Societe Des Produits Nestle S.A.	Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
BR112021016924A2 (pt) *	2019-03-05	2021-11-03	Glycom As	Oligossacarídeos do leite humano para uso no aprimoramento da função executiva
WO2022117710A1 (en)	2020-12-04	2022-06-09	Société des Produits Nestlé S.A.	Stable aqueous composition for preterm to promote early postnal growth
CN114223723A (zh) *	2021-12-13	2022-03-25	黑龙江飞鹤乳业有限公司	营养组合物、包含其的食品以及该营养组合物的用途
KR102570073B1 (ko) *	2022-11-17	2023-08-24	(주)에이피테크놀로지	2'-푸코실락토오스를 포함하는 치매 개선 또는 치료용조성물
CN118105395A (zh) *	2023-12-29	2024-05-31	澳优乳业（中国）有限公司	低聚糖2’-fl在制备用于改善神经发育和改善功能障碍的产品中的应用
WO2025257135A1 (en)	2024-06-10	2025-12-18	N.V. Nutricia	Non-digestible oligosaccharide mixture for infants at risk of brain injury
CN120959408A (zh) *	2024-12-20	2025-11-18	飞鹤(阿鲁科尔沁旗)乳品有限公司	辅助改善记忆能力的营养组合物的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU694181B2 (en) *	1994-03-09	1998-07-16	Abbott Laboratories	Humanized milk
KR970706271A (ko)	1994-09-20	1997-11-03	스티븐슨 린다 에스.	시냅스 전달 향상용 약제(drugs to improve synaptic transmission)
HUP0300236A3 (en)	1997-02-21	2003-09-29	Univ Tennessee Res Corp Knoxvi	Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation
US6365218B1 (en)	2000-02-04	2002-04-02	Abbott Laboratories	Pediatric formula and methods for providing nutrition and improving tolerance
US6811801B2 (en)	2001-12-12	2004-11-02	Abbott Laboratories	Methods and compositions for brightening the color of thermally processed nutritionals
US20110104716A1 (en) *	2003-08-08	2011-05-05	Hasan Mohejeri	Novel method for screening brain-active compounds
US7897637B2 (en)	2006-07-19	2011-03-01	The Salk Institute For Biological Studies	Methods of using flavonoids to enhance memory
EP2438821B1 (en)	2008-11-03	2020-01-15	Société des Produits Nestlé S.A.	A nutritional composition comprising probiotics and improving sleep patterns
CA2758097A1 (en) *	2009-04-07	2010-10-14	Glycom A/S	Synthesis of 2'-o-fucosyllactose
JP2012532195A (ja)	2009-07-06	2012-12-13	チルドレンズホスピタルメディカルセンター	乳オリゴ糖による炎症の阻害
ES2804258T3 (es)	2010-12-31	2021-02-05	Abbott Lab	Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
ES2667393T3 (es)	2010-12-31	2018-05-10	Abbott Laboratories	Oligosacáridos de leche humana para modular inflamación
MY191538A (en) *	2010-12-31	2022-06-30	Abbott Lab	Human milk oligosaccharides to promote growth of beneficial bacteria
MY166945A (en) *	2010-12-31	2018-07-25	Abbott Lab	Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
WO2012092155A1 (en) *	2010-12-31	2012-07-05	Abbott Laboratories	Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
CN107019701B (zh) *	2010-12-31	2020-07-28	雅培制药有限公司	使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
WO2013057049A1 (en)	2011-10-18	2013-04-25	Nestec S.A.	Composition for use in brain growth and/or cognitive and/or psychomotor development
ES2572831T3 (es)	2012-09-14	2016-06-02	Abbott Laboratories	Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico

2012
- 2012-09-14 EP EP12382356.9A patent/EP2708147B1/en not_active Revoked
- 2012-09-14 ES ES12382356T patent/ES2795665T3/es active Active
- 2012-09-14 EP EP20161856.8A patent/EP3704957A1/en active Pending
- 2012-09-14 DK DK12382356.9T patent/DK2708147T3/da active
2013
- 2013-09-12 MY MYPI2015000615A patent/MY180148A/en unknown
- 2013-09-12 CN CN201380059274.1A patent/CN104780785A/zh active Pending
- 2013-09-12 SG SG11201501893XA patent/SG11201501893XA/en unknown
- 2013-09-12 US US14/428,247 patent/US10398715B2/en active Active
- 2013-09-12 WO PCT/US2013/059488 patent/WO2014043368A1/en not_active Ceased
- 2013-09-12 BR BR112015005794A patent/BR112015005794A2/pt not_active IP Right Cessation
- 2013-09-12 MX MX2015003425A patent/MX385855B/es unknown
- 2013-09-12 CA CA2884634A patent/CA2884634A1/en not_active Abandoned
2015
- 2015-03-08 IL IL237617A patent/IL237617A0/en unknown
- 2015-03-13 PH PH12015500546A patent/PH12015500546A1/en unknown
- 2015-03-13 MX MX2021010492A patent/MX2021010492A/es unknown

Also Published As

Publication number	Publication date
EP2708147A8 (en)	2014-09-03
US10398715B2 (en)	2019-09-03
PH12015500546A1 (en)	2015-05-11
MX2015003425A (es)	2015-06-22
CA2884634A1 (en)	2014-03-20
MY180148A (en)	2020-11-23
BR112015005794A2 (pt)	2017-07-04
CN104780785A (zh)	2015-07-15
SG11201501893XA (en)	2015-04-29
MX2021010492A (es)	2021-10-01
MX385855B (es)	2025-03-18
EP2708147B1 (en)	2020-03-11
IL237617A0 (en)	2015-04-30
US20150231159A1 (en)	2015-08-20
ES2795665T3 (es)	2020-11-24
EP3704957A1 (en)	2020-09-09
WO2014043368A1 (en)	2014-03-20
EP2708147A1 (en)	2014-03-19

Publication	Publication Date	Title
DK3225604T3 (da)	2019-06-17	Fremgangsmåde til fremstilling af flerlagsruder
DK2906696T3 (da)	2019-11-25	Fremgangsmåder til modulering af c9orf72-ekspression
DK3006568T3 (da)	2019-10-07	Fremgangsmåde til fremstilling af tagatose
DK3083540T3 (da)	2020-02-24	Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner
DK2897620T3 (da)	2020-08-17	Fremgangsmåde til behandling af cancer
DK2935299T3 (da)	2019-11-18	Glycokonjugationsfremgangsmåde
CO7010838A2 (es)	2014-07-31	Compuestos de imidazopirrolidinona
DE112013000673T8 (de)	2014-12-24	Filtervorrichtung
DK3454346T3 (da)	2021-11-01	Anordning til cylotronfremstilling af technetium-99m
SG11201501893XA (en)	2015-04-29	Methods for increasing brain functionality using 2-fucosyl-lactose
BR112014028487A2 (pt)	2017-06-27	braçadeira
EP2928525A4 (en)	2016-12-21	SYRINGE LABELING
DK2849760T3 (da)	2020-02-03	Fremgangsmåder til oligonukleotid-chelatkompleks
BR112014021748A2 (pt)	2017-06-20	conjunto de grampo
DK3065790T3 (da)	2021-02-01	Fremgangsmåder til fjernelse af alpha-galactose
DK2908724T3 (da)	2022-09-12	Fremgangsmåde til at følge udviklingen af en hjernelæsion
DK3369724T3 (da)	2021-03-29	Fremgangsmåde til fremstilling af iopamidol
DK2870252T3 (da)	2020-03-16	Fremgangsmåder ved anvendelse af patatin
DK2809782T3 (da)	2017-11-20	Forbedret fremgangsmåde til fremstilling af makrokugler
DOS2012000293S (es)	2013-03-31	Sarten
DK2732707T3 (da)	2016-02-08	Fremgangsmåde til fremstilling af en sammensætning indeholdende caseinomacropeptid
DK2863985T3 (da)	2017-11-06	Anordning til forbedring af mikrocirkulering
DK3398594T3 (da)	2024-09-23	Sammensætninger til forbedring af hjernefunktion
DK2916661T3 (da)	2019-06-03	Fremgangsmåde til opnåelse af bloom-hæmmende komponenter til konfektureprodukter
DK2872536T3 (da)	2019-11-25	Fremgangsmåde til ekstraktion af biomasse